Pregnane receptor gene polymorphisms, pathogenic bacteria distribution and drug sensitivity, and TCM syndrome differentiation in patients with cholelithiasis.

[1]  M. Huang,et al.  Hepatoprotective Effects of Schisandra sphenanthera Extract against Lithocholic Acid–Induced Cholestasis in Male Mice Are Associated with Activation of the Pregnane X Receptor Pathway and Promotion of Liver Regeneration , 2016, Drug Metabolism and Disposition.

[2]  Xi Ma,et al.  Pregnane X Receptor as the “Sensor and Effector” in Regulating Epigenome , 2015, Journal of cellular physiology.

[3]  M. Trauner,et al.  New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. , 2015, Journal of hepatology.

[4]  Byung-Hoon Lee,et al.  Expression of CYP3A in chronic ethanol-fed mice is mediated by endogenous pregnane X receptor ligands formed by enhanced cholesterol metabolism , 2015, Archives of Toxicology.

[5]  Se-hyung Park,et al.  Intestinal pregnane X receptor links xenobiotic exposure and hypercholesterolemia. , 2015, Molecular Endocrinology.

[6]  F. Baldelli,et al.  Targeting FXR in cholestasis: hype or hope , 2014, Expert opinion on therapeutic targets.

[7]  Hui Tang,et al.  Cholelithiasis and risk of pancreatic cancer: systematic review and meta-analysis of 21 observational studies , 2014, Cancer Causes & Control.

[8]  J. Cullen,et al.  Role of human pregnane X receptor in high fat diet-induced obesity in pre-menopausal female mice. , 2014, Biochemical pharmacology.

[9]  Minarda De la O-Arciniega,et al.  Intestinal and hepatic Niemann-Pick C1L1 proteins: future therapeutic targets for cholesterol gallstones disease? , 2014, European journal of pharmacology.

[10]  M. Büchler,et al.  Bacteriobilia and fungibilia are associated with outcome in patients with endoscopic treatment of biliary complications after liver transplantation , 2013, Endoscopy.

[11]  B. Liu,et al.  Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study , 2013, BMC Genomics.

[12]  I. Kotta-Loizou,et al.  Pregnane X receptor polymorphisms associated with human diseases , 2013, Expert opinion on therapeutic targets.

[13]  P. Portincasa,et al.  Current Views on Genetics and Epigenetics of Cholesterol Gallstone Disease , 2013, Cholesterol.

[14]  S. Zeng,et al.  Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond , 2013, Expert opinion on drug metabolism & toxicology.

[15]  W. Xie,et al.  Targeting xenobiotic receptors PXR and CAR for metabolic diseases. , 2012, Trends in pharmacological sciences.

[16]  M. Downes,et al.  FXR and PXR: Potential therapeutic targets in cholestasis , 2012, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  M. Makishima,et al.  PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts. , 2011, Gastroenterology.